Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Dixon, , Pamela,
DOB: 01-DEC-1990 (Age: 34)
Gender: female
Address:
6 Diana landing
M14 Claireport (United Kingdom)
ID: 6166-148600-3 (ECI)
Report
Date: 08-APR-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Cornbrook Medical Practice
City Road 204
M3 3 Manchester (United Kingdom)
Specimen
Collected: 08-APR-2023

Chemistry

Test 08-APR-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 194.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 133.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 118.0 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.1 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within normal limits. Cholesterol, LDL, HDL, and triglycerides are in the desirable range, indicating no current dyslipidemia. No laboratory evidence of increased cardiovascular risk based on these results. Recommend routine follow-up as clinically indicated.